Meeting
2015 ASCO Annual Meeting
The role of LHRH agonists in ovarian function preservation in premenopausal women undergoing chemotherapy for early stage breast cancer: A systematic review and meta-analysis.
Authors
Rodrigo Ramella Munhoz
Memorial Sloan Kettering Cancer Center, New York, NY
Rodrigo Ramella Munhoz , Allan Andresson Lima Pereira , Andre Deeke Sasse , Paulo Marcelo Hoff , Tiffany A. Traina , Clifford A. Hudis , Ricardo Jose Marques
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Cytotoxic Chemotherapy
Citation
J Clin Oncol 33, 2015 (suppl; abstr 1050)
DOI
10.1200/jco.2015.33.15_suppl.1050
Abstract #
1050
Poster Bd #
164
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Estradiol (E2) levels in premenopausal women with hormone receptor-positive (HR+) breast cancer (BC) on ovarian function suppression (OFS) with gonadotropin-releasing hormone agonists (GnRHa).
First Author: Megan Elizabeth Tesch
Poster
2021 ASCO Annual Meeting
Final analysis of the PROMISE-GIM6 phase III trial assessing GnRH agonist use during chemotherapy as a strategy to preserve ovarian function in premenopausal patients with early breast cancer.
First Author: Matteo Lambertini
Poster
2018 ASCO Annual Meeting
Ribociclib (RIB) + tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) in premenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC) who received prior chemotherapy (CT): MONALEESA-7 subgroup analysis.
First Author: Sara A. Hurvitz
Poster
2014 Breast Cancer Symposium
Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog (LHRHa) during chemotherapy (CT) as a strategy to reduce ovarian failure in early breast cancer (BC) patients.
First Author: Matteo Lambertini